Cyrille Abel Sébastien Landreau

Title: Cyrille Abel Sébastien Landreau: Innovator in Molybdopterin Precursor Synthesis

Introduction

Cyrille Abel Sébastien Landreau is a notable inventor based in Essex, GB. He has made significant contributions to the field of synthetic chemistry, particularly in the development of methods for synthesizing molybdopterin precursor Z derivatives. His work is crucial for advancing treatments for diseases associated with molybdenum cofactor deficiency.

Latest Patents

Cyrille holds a patent for "Methods for synthesizing molybdopterin precursor Z derivatives." This patent outlines synthetic methods for preparing compounds of formula (I) and formula (XIII). The disclosure also includes useful intermediates, derivatives, prodrugs, and pharmaceutically acceptable salts, solvates, and hydrates of these compounds. These innovations are essential for developing therapies for specific medical conditions.

Career Highlights

Throughout his career, Cyrille has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Alexion Pharmaceuticals, Inc. and Alexion Pharma International Sarl. His experience in these organizations has allowed him to contribute to significant advancements in drug development.

Collaborations

Cyrille has collaborated with esteemed colleagues, including Xiangtian Long and Danmei Dai. These partnerships have fostered a collaborative environment that enhances innovation and research in their field.

Conclusion

Cyrille Abel Sébastien Landreau is a distinguished inventor whose work in synthetic chemistry has the potential to impact medical treatments significantly. His contributions to the synthesis of molybdopterin precursor Z derivatives exemplify the importance of innovation in addressing complex health issues.